Surgery & Radiation (Locoregional Therapy) for MBC: Remaining Questions - Metastatic Breast Cancer Trial Talk

Research News

The headlines announcing the results of a phase III clinical trial (ECOG-ACRIN 2108) stated that radiation and surgery to the breast–also called locoregional therapy (LRT)– for people with de novo metastatic breast cancer did not increase survival. However, despite the headlines, the common practice is still to decide on a case-by-case basis if locoregional therapy to the breast ought to be given after a diagnosis of metastatic disease. This approach to using LRT continues because there are still unanswered questions and ongoing research.

See below for links discussing the trial, remaining research questions and other reasons someone might choose LRT.



for past articles or specific information.